Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDL.L Regulatory News (SDL)

  • There is currently no data for SDL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - AXA INVESTMENT MANAGERS: SDL PLC dealings

14 Sep 2020 14:43

Form 8.3 - AXA INVESTMENT MANAGERS: SDL PLC dealings

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:AXA Investment Managers S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree SDL PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 11th September 2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” YES: RWS Holdings PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary share
InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:3 294 3493.61%  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL: AXA Investment Managers doesnot have discretion regardingvoting decisions in respect of1 552 613 shares that are included in this total. 3 294 349 3.61%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
1p ordinarySale1 816GBP 7.35
1p ordinarySale1 589GBP 7.33
1p ordinarySale10 536GBP 7.35
1p ordinarySale9 215GBP 7.33

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:14th September 2020
Contact name:Anthony Gilsoul
Telephone number*:+33 1 44 45 97 54

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
15th May 20174:46 pmRNSHolding(s) in Company
15th May 20178:35 amRNSHolding(s) in Company
5th May 201712:34 pmRNSAnnual Financial Report
3rd May 20178:13 amRNSHolding(s) in Company
27th Apr 201710:45 amRNSAGM Statement
21st Apr 20179:33 amRNSDirector/PDMR Shareholding
20th Apr 201711:30 amRNSDirector/PDMR Shareholding
20th Apr 201711:27 amRNSTotal Voting Rights
20th Apr 20177:00 amRNSDisposal of Social Intelligence
5th Apr 20175:45 pmRNSHolding(s) in Company
4th Apr 20176:05 pmRNSHolding(s) in Company
21st Mar 20174:25 pmRNSApplication for Blocklisting
21st Mar 20174:11 pmRNSIssue of Equity
16th Mar 201711:10 amRNSDirector/PDMR Shareholding
8th Mar 20178:01 amRNSCompletion of disposal
7th Mar 20172:44 pmRNSDividend Declaration
7th Mar 20177:00 amRNSFinal Results
28th Feb 20177:00 amRNSTotal Voting Rights
24th Feb 20173:10 pmRNSHolding(s) in Company
14th Feb 20177:00 amRNSAppointment of Chief Product Officer
31st Jan 20174:34 pmRNSHolding(s) in Company
30th Jan 20177:15 amRNSDisposal of Fredhopper
20th Jan 20177:00 amRNS2016 Year-end Trading Update
5th Jan 20173:24 pmRNSBlock listing Interim Review
29th Dec 20163:52 pmRNSHolding(s) in Company
7th Dec 20163:25 pmRNSDirector/PDMR Shareholding
6th Dec 20167:00 amRNSCapital Markets Presentation
15th Nov 201610:11 amRNSHolding(s) in Company
3rd Nov 20167:00 amRNSDisposal of Campaigns business
2nd Nov 20164:26 pmRNSHolding(s) in Company
31st Oct 201610:07 amRNSHolding(s) in Company
21st Oct 20163:17 pmRNSHolding(s) in Company
5th Oct 20163:20 pmRNSTotal Voting Rights
22nd Sep 20169:51 amRNSHolding(s) in Company
5th Sep 201610:42 amRNSTotal Voting Rights
2nd Sep 201610:30 amRNSHolding(s) in Company
26th Aug 201611:11 amRNSHolding(s) in Company
23rd Aug 201610:29 amRNSHolding(s) in Company
18th Aug 20165:16 pmRNSHolding(s) in Company
9th Aug 20163:56 pmRNSTotal Voting Rights
4th Aug 20162:30 pmRNSHolding(s) in Company
3rd Aug 20163:24 pmRNSDirector/PDMR Shareholding
2nd Aug 20167:00 amRNSHalf-year Report
19th Jul 20162:05 pmRNSNotice of Results
5th Jul 20169:24 amRNSTotal Voting Rights
5th Jul 20169:23 amRNSHolding(s) in Company
1st Jul 201612:23 pmRNSDirector Declaration
22nd Jun 201611:23 amRNSDirector/PDMR Shareholding
8th Jun 20169:40 amRNSDirectorate Change
6th Jun 20168:00 amRNSAppointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.